Medtronic Under Fire for Using Corrupt Research to Promote INFUSE Bone Graft Product

Comments: www.kcrlegal.com In July 2011, national spine care medical journal, The Spine Journal, devoted their entire issue to the controversial Medtronic INFUSE® BMP-2 bone graft product. The journal's editors were compelled to act upon reports that doctors paid by Medtronic were aware of Infuse's potentially life threatening side effects, yet neglected to reveal those complications in published journal articles. The articles published in the July 2011 issue of The Spine Journal exposed the following problems: Use of Infuse bone graft medical device in spinal fusion surgeries could result in severe injury to the patient's nerves and spinal cord Off-label use of Infuse in cervical spine surgery and certain types of lumbar spine surgeries may result in severe side effects, or when used in neck surgery, death Medtronic failed to report these harmful side effects that were revealed in clinical trials Medtronic neglected to report that many of the surgeons and researchers promoting Infuse were paid by Medtronic For more information about Medtronic Infuse, or to file a claim for problems with the Infuse bone graft product, call 888-285-3333 or visit www.kcrlegal.com